Senate vote looms on user fee legislation

The Senate could begin voting today on vital user fee legislation for both the medical device and drug industries, Bloomberg reports. Fees for device companies are set to more than double to $609 million, the article notes, with the money set to help fuel the safety and efficacy reviews regulators conduct before a product is approved for the market. The legislation is also supposed to mandate more post-marketing studies and launch a way to electronically track devices. But the industry beat back efforts to prevent devices of low- to medium-risk from gaining clearance if a related device got slapped with a recall over safety reasons. Story


Suggested Articles

Sherlock Biosciences teamed up with Cepheid to help develop its CRISPR-based molecular diagnostic tech in oncology, infections and the coronavirus.

The spine surgery company ATEC has moved to acquire Paris-based EOS imaging, makers of FDA-cleared scanners and 3D orthopedic planning software.

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.